| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein |
| 03/13/2001 | US6200751 Cell preferential regulatory sequences; for the control of transcription from heterologous nucleotide sequences; for use in gene therapy |
| 03/13/2001 | US6200749 Ajusted nucleic acid sequence; for detection of genome adjustments and preferential genetic disorders |
| 03/13/2001 | US6200622 Frozen food product |
| 03/13/2001 | US6200578 Genetic engineered polypeptide |
| 03/13/2001 | US6200577 Anti-herpesviral agents and assays therefor |
| 03/13/2001 | US6200576 Swine vesicular disease virus and mutant strains and preparation process and use thereof |
| 03/13/2001 | US6200575 These new ?inactivated? immunogens can be used to induce active immunization in humans which is capable of preventing or correcting the deregulatory effects which the native proteins from which they are produced may help to produce. |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | US6200560 Adeno-associated virus vectors for expression of factor VIII by target cells |
| 03/13/2001 | US6200559 Use of antibodies against MxA or MxB to determine levels of type I interferons in vivo |
| 03/13/2001 | US6200546 Gastrin receptor-avid peptide conjugates |
| 03/13/2001 | CA2125673C Dna structure-specific recognition protein and uses therefor |
| 03/13/2001 | CA1341204C Analogues of igf-1 and igf-2 |
| 03/13/2001 | CA1341203C Eukaryotic fusion proteins, containing interleukin-2 sequences |
| 03/08/2001 | WO2001016605A2 Identifying modulators of transcriptional activator protein interactions |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016601A1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/08/2001 | WO2001016596A2 Screening for modulators of gaba b receptor activity |
| 03/08/2001 | WO2001016379A1 Hepatitis c virus replication inhibitors |
| 03/08/2001 | WO2001016364A2 Methods of diagnosing or prognosticating age-related macular degeneration |
| 03/08/2001 | WO2001016354A1 Modulation of he4 in inflammatory and renal diseases |
| 03/08/2001 | WO2001016351A1 DnaE |
| 03/08/2001 | WO2001016344A1 Modified adenoviral fibre and uses thereof |
| 03/08/2001 | WO2001016340A1 Flax seed specific promoters |
| 03/08/2001 | WO2001016339A1 Use of arabinogalactan protein fusion constructs in a method of expressing proteins and peptides in plants |
| 03/08/2001 | WO2001016332A1 Gene encoding protein participating in signal transduction of cytokinin |
| 03/08/2001 | WO2001016331A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 03/08/2001 | WO2001016330A2 Prevention of affections associated with porcine circovirus-2 |
| 03/08/2001 | WO2001016328A2 Method for the production of regular nanostructures |
| 03/08/2001 | WO2001016327A2 Method for producing a channel-forming protein |
| 03/08/2001 | WO2001016326A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 03/08/2001 | WO2001016325A2 Plant reproduction proteins |
| 03/08/2001 | WO2001016324A2 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | WO2001016323A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016321A1 Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof |
| 03/08/2001 | WO2001016320A1 Isolated nona and decapeptides which bind to hla molecules, and the use thereof |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016318A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | WO2001016317A2 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | WO2001016316A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |
| 03/08/2001 | WO2001016313A1 Human gs protein regulator gene |
| 03/08/2001 | WO2001016311A1 HUMAN 1p36 HOMOZYGOSITY DELETION DOMAIN |
| 03/08/2001 | WO2001016309A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | WO2001016307A2 Plant promoter sequences from maize for selective control of gene expression |
| 03/08/2001 | WO2001016305A2 Nucleotide sequences encoding an insectidal protein complex from serratia |
| 03/08/2001 | WO2001016303A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 03/08/2001 | WO2001016298A1 Cloning of mouse gpr10 receptor |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016295A1 Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016291A2 07cg27 gene |
| 03/08/2001 | WO2001016211A1 Amphipathic compound having dendritic structure |
| 03/08/2001 | WO2001016183A1 Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein |
| 03/08/2001 | WO2001016182A2 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 03/08/2001 | WO2001016181A2 Crystal structures of domains of receptor protein tyrosine kinases and their ligands |
| 03/08/2001 | WO2001016180A2 Cd40 agonist compositions and methods of use |
| 03/08/2001 | WO2001016179A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | WO2001016178A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 03/08/2001 | WO2001016177A1 Mouse g-protein coupled 7 transmembrane receptor, canoman |
| 03/08/2001 | WO2001016176A2 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | WO2001016175A1 A novel human rab gene and its coding polypeptide |
| 03/08/2001 | WO2001016174A2 Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65 |
| 03/08/2001 | WO2001016172A1 Vaccine antigens of moraxella |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016169A2 RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE |
| 03/08/2001 | WO2001016168A2 Induction of programmed cell death by n5 gene |
| 03/08/2001 | WO2001016167A2 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 03/08/2001 | WO2001016166A2 Polypeptides, comprising il-6 ligand-binding receptor domains, and related nucleic acids, antibodies, compositions, and methods of use |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016163A2 Peptide mixture and vaccine against a chronic viral infection |
| 03/08/2001 | WO2001016161A1 SYNTHESIS OF TEMPLATE-FIXED β-HAIRPIN LOOP MIMETICS |
| 03/08/2001 | WO2001016159A1 Gpcr, theant |
| 03/08/2001 | WO2001016158A2 Bridging integrator-2 (bin2) nucleic acid molecules and proteins and uses therefor |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016153A1 Cytomegalovirus-encoded il-10 homolog |
| 03/08/2001 | WO2001016144A2 Plant derived calcium-dependent calmodulin-binding polypeptides and polynucleotides encoding same |
| 03/08/2001 | WO2001015741A2 Genetic suppressor elements against human immunodeficiency virus |
| 03/08/2001 | WO2001015737A2 Method for coupling molecules |
| 03/08/2001 | WO2001015731A1 Compositions and methods for the treatment of sepsis using antibodies to c5a |
| 03/08/2001 | WO2001015729A1 Connective tissue growth factor receptor, its agonists and antagonists, and their therapeutic and diagnostic uses |
| 03/08/2001 | WO2001015721A1 Novel uses of semaphorin and vegf |
| 03/08/2001 | WO2001015709A1 USE OF rAFP TO INHIBIT OR PREVENT APOPTOSIS |
| 03/08/2001 | WO2001015708A1 Vaccine to control equine protozoal myeloencephalitis in horses |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015655A2 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders |
| 03/08/2001 | WO2001015521A1 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 03/08/2001 | WO2001015520A1 Pa28 modified transgenic mice |
| 03/08/2001 | WO2001000840A9 Insecticidal and nematicidal proteins |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000061634A3 Ecotin-variant modulators of serine proteases |
| 03/08/2001 | WO2000061624A8 48 human secreted proteins |